4-azido-2-chloro-1-fluorobenzene | 85862-85-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-azido-2-chloro-1-fluorobenzene
• 英文别名: 3-chloro-4-fluorophenyl azide；4-fluoro-3-chlorophenyl azide
• CAS: 85862-85-7
• 化学式: C₆H₃ClFN₃
• mdl: MFCD00211406
• 分子量: 171.561
• InChiKey: CPTIGEURUINHDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  14.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-azido-2-chloro-1-fluorobenzene 在 copper(II) acetate monohydrate 作用下， 以 水 、 丙酮 、 叔丁醇 为溶剂， 反应 18.33h， 生成 1-(3-chloro-4-fluorophenyl)-1H-(1,2,3)triazol-4-carbaldehyde
  参考文献：
  名称：

  Synthesis of novel 1-substituted triazole linked 1,2-benzothiazine 1,1-dioxido propenone derivatives as potent anti-inflammatory agents and inhibitors of monocyte-to-macrophage differentiation

  摘要：

  化合物12g，12i和12l通过抑制单核细胞分化来调节促炎细胞因子的产生。

  DOI：

  10.1039/c5md00171d
• 作为产物：
  描述：

  3-chloro-4-fluorobenzenediazonium tetrafluoroborate 在 sodium azide 作用下， 以 乙腈 为溶剂， 生成 4-azido-2-chloro-1-fluorobenzene
  参考文献：
  名称：

  Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO)

  摘要：

  Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO), which mediate kynurenine pathway of tryptophan degradation, have emerged as potential new targets in immunotherapy for treatment of cancer because of their critical role in immunosuppression in the tumor microenvironment. In this investigation, we report the structural optimization and structure-activity relationship studies of 1-phenyl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as a new class of IDO1/TDO dual inhibitors. Among all the obtained dual inhibitors, 1-(3-chloro-4-fluorophenyl)-6-fluoro-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione (38) displayed the most potent IDO1 and TDO inhibitory activities with IC₅₀ (half-maximal inhibitory concentration) values of 5 nM for IDO1 and 4 nM for TDO. It turned out that compound 38 was not a PAINS compound. Compound 38 could efficiently inhibit the biofunction of IDO1 and TDO in intact cells. In LL2 (Lewis lung cancer) and Hepa1-6 (hepatic carcinoma) allograft mouse models, this compound also showed considerable in vivo anti-tumor activity and no obvious toxicity was observed. Therefore, 38 could be a good lead compound for cancer immunotherapy and deserving further investigation.

  DOI：

  10.1016/j.ejmech.2020.112703

文献信息

• Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities
  作者：Rama Kant、Dharmendra Kumar、Drishti Agarwal、Rinkoo Devi Gupta、Ragini Tilak、Satish Kumar Awasthi、Alka Agarwal

  DOI：10.1016/j.ejmech.2016.02.041

  日期：2016.5

  The antiplasmodial and cytotoxic activities of these compounds were also evaluated against human malaria parasite Plasmodium falciparum strain 3D7 and human hepato-cellular carcinoma cells (Huh-7), respectively. Compounds 10a, 10c, 10d, 12c and 14e showed promising antibacterial activity while compounds 10e, 11d, 11e, 12c, 13a, 13b, 13e, 14a and 14d showed good antifungal activity as compared to the corresponding

  本研究旨在通过铜催化点击化学合成一类新的抗菌剂和抗疟原虫剂，以提供25种1,4-二取代-1,2,3-三唑的化合物10–14（a – e）。查耳酮和黄酮的衍生物。通过元素分析，IR，1 H NMR，13 C NMR和质谱数据建立了新合成化合物的结构。评价了新合成的化合物对革兰氏阳性细菌（金黄色葡萄球菌，粪肠球菌），革兰氏阴性细菌（大肠杆菌，铜绿假单胞菌，志贺氏菌鲍氏，肺炎克雷伯菌）和抗真菌活性（白色念珠菌，热带念珠菌，近平滑念珠菌，新型隐球菌，皮肤癣菌）以及模具（黑曲霉，烟曲霉）。还分别评估了这些化合物对人疟原虫恶性疟原虫菌株3D7和人肝细胞癌细胞（Huh-7）的抗血浆和细胞毒活性。化合物10a，10c，10d，12c和14e与相应的标准药物相比，化合物10e，11d，11e，12c，13a，13b，13e，14a和14d表现出良好的抗菌活性。发现化合物10b对恶性疟原虫最具活性，而其余化合
• Synthesis, Characterization and Antitumor Activity of Novel Triazole/ Isoxazole Tagged Pyridine Hybrids
  作者：Raju K、Chandra A、Sathaiah G、Ravi A、Narsaiah B、Shanthan P、Srujana R、Srigiridhar Kotamraju

  DOI：10.2174/1570178610666131118223356

  日期：2014.2

  A series of novel 2-((1-substituted-1H-1,2,3-triazol-4-yl/3-substitutedisoxazol-5-yl)methoxy) substituted pyridine, 1-((1-substituted-1H-1,2,3-triazol-4-yl/3-substitutedisoxazol-5-yl)methyl)substituted pyridin-2(1H)-one was prepared from 2-oxo-6-phenyl/methyl-4-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile 3 via propargylation followed by 1,3- dipolar cycloaddition of the propargyl derivatives 4 and 5. These triazole/isoxazole tagged pyridine derivatives were evaluated for antitumor activity against breast cancer cell lines such as MDA-MB-231, MCF-7 etc. The results indicated that compounds 6e, 6f, 8e and 8f were found to be active on MDA-MB-231, while 6h and 8h were active on MCF-7.

  一系列新型2-((1-取代的1H-1,2,3-三唑-4-基/3-取代的异恶唑-5-基)甲氧基)取代的吡啶、1-((1-取代的1H-1,2,3-三唑-4-基/3-取代的异恶唑-5-基)甲基)取代的吡啶-2(1H)-酮，从2-氧代-6-苯基/甲基-4-(三氟甲基)-1,2-二氢吡啶-3-氰化物3经炔丙基化，随后进行炔丙基衍生物4和5的1,3-偶极环加成反应制备。这些三唑/异恶唑标记的吡啶衍生物对乳腺癌细胞系如MDA-MB-231、MCF-7等进行抗肿瘤活性评估。结果表明，化合物6e、6f、8e和8f对MDA-MB-231有活性，而6h和8h对MCF-7有活性。
• Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents
  作者：Hunsur Nagendra Nagesh、Kalaga Mahalakshmi Naidu、Damarla Harika Rao、Jonnalagadda Padma Sridevi、Dharmarajan Sriram、Perumal Yogeeswari、Kondapalli Venkata Gowri Chandra Sekhar

  DOI：10.1016/j.bmcl.2013.10.016

  日期：2013.12

  Focus in this Letter is made to design and synthesize a series of nineteen new 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues employing click chemistry and evaluated for their anti-tubercular activity against Mycobacterium tuberculosis H37Rv. Among the tested compounds, 7f and 7j exhibited good activity (MIC = 3.125 μg/mL), while 8a displayed excellent activity

  本信的重点是设计和合成一系列十九种新的使用（6-（4-（（取代的-1 H -1,2,3-三唑-4-基）甲基）哌嗪-1-基）菲啶类似物的6-（4-（（（取代的-1 H -1,2,3-三唑-4-基）甲基）哌嗪-1-基）菲啶类似物单击化学，并评估其对结核分枝杆菌H 37 Rv的抗结核活性。在测试的化合物中，7f和7j表现出良好的活性（MIC = 3.125μg/ mL），而8a表现出优异的活性（MIC = 1.56μg/ mL），对结核分枝杆菌H 37 Rv的生长具有抑制作用。此外，7f，7j和8a对化合物进行了针对小鼠巨噬细胞（RAW264.7）细胞系的细胞毒性研究，其选择性指数值大于15，表明该化合物适用于进一步的药物开发。
• Design, Synthesis, and Biological Evaluation of 2-(4-Aminophenyl)benzothiazole Analogues as Antiproliferative Agents
  作者：Suresh Narva、Surendar Chitti、Suresh Amaroju、Sridhar Goud、Mallika Alvala、Debanjan Bhattacharjee、Nishant Jain、Chandra Sekhar Kondapalli Venkata Gowri

  DOI：10.1002/jhet.3427

  日期：2019.2

  A series of 28 novel 2‐(4‐aminophenyl)benzothiazole analogues have been synthesized and characterized using various analytical techniques like 1H NMR, 13C NMR, electrospray ionization mass spectrometry, and IR and bioevaluated for their antiproliferative activity over a group of three human cancer cell lines, namely, lung cancer (A549), cervical cancer (HeLa), and breast cancer (MDA‐MB‐231), using

  已使用1 H NMR，13 C NMR，电喷雾电离质谱和IR等多种分析技术合成和表征了28个新颖的2-（4-氨基苯基）苯并噻唑类似物，并对它们在三个组中的抗增殖活性进行了生物评估使用磺基罗丹明B检测方法检测人类癌细胞系，即肺癌（A549），子宫颈癌（HeLa）和乳腺癌（MDA-MB-231）。很少有合成分子（5a，5c，5d，5f，7b和7j）显示出有效的生长抑制作用（GI 50））在0.2–1.7μM范围内的较低微摩尔浓度（GI 50）值下对被测人癌细胞系的活性。值得注意的是，化合物7b在GI 50范围为0.55–1.2μM的所有三种癌细胞系中均显示出合理的活性。此外，当筛选7b的微管蛋白聚合抑制时，在浓度为5.0μM时，其抑制率超过55％。分子对接模拟支持衍生物与靶向受体的分子相互作用。这些衍生物可以用作潜在的抗癌药物候选物开发的先导结构，而7b可以用作潜在的微管聚合抑制剂。
• Design, Synthesis and Anti-Platelet Aggregation Activity Study of Ginkgolide-1,2,3-triazole Derivatives
  作者：Jian Cui、Le’An Hu、Wei Shi、Guozhen Cui、Xumu Zhang、Qing-Wen Zhang

  DOI：10.3390/molecules24112156

  日期：——

  Ginkgolides are the major active component of Ginkgo biloba for inhibition of platelet activating factor receptor. An azide-alkyne Huisgen cycloaddition reaction was used to introduce a triazole nucleus into the target ginkgolide molecules. A series of ginkgolide-1,2,3-triazole conjugates with varied functional groups including benzyl, phenyl and heterocycle moieties was thus synthesized. Many of the designed derivatives showed potent antiplatelet aggregation activities with IC50 values of 5~21 nM.

  银杏内酯是银杏叶中抑制血小板活化因子受体的主要活性成分。使用叠氮-炔Huisgen环加成反应将三唑核引入目标银杏内酯分子中。因此合成了一系列具有苯甲基、苯基和杂环基团等不同功能基团的银杏内酯-1,2,3-三唑共轭物。许多设计的衍生物显示出强效的抗血小板聚集活性，IC50值为5~21 nM。